semaglutide oral (AdOral Sema)
/ Adocia
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 19, 2025
ADORAL®—A VERSATILE PLATFORM FOR IMPROVED ORAL PEPTIDE ABSORPTION
(ATTD 2025)
- "In dogs, AdOral® capsules allowed oral absorption of semaglutide and insulin lispro, demonstrating the versatility of the platform. AdOral® semaglutide showed 2.5-fold improvement in median semaglutide AUC0-5h and bioavailability vs. Rybelsus®.Conclusions Thus, AdOral® is a versatile and performant platform that could lead to cost-effective oral formulations for a wide range of therapeutic peptides."
June 28, 2024
Groundbreaking Research Alert: Semaglutide's Impact on Heart Failure
(YouTube)
- "New findings reveal that Semaglutide, a drug originally developed for type 2 diabetes and obesity, offers significant benefits for both men and women suffering from heart failure with preserved ejection fraction (HFpEF), especially those struggling with obesity....Sanjiv J. Shah..."
Video
1 to 2
Of
2
Go to page
1